Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn’s Disease Is Determined by Their Concentration
Crossref DOI link: https://doi.org/10.1208/s12248-016-9989-8
Published Online: 2016-10-13
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Edlund, Helena
Steenholdt, Casper
Ainsworth, Mark A.
Goebgen, Eva
Brynskov, Jørn
Thomsen, Ole Ø.
Huisinga, Wilhelm
Kloft, Charlotte
License valid from 2016-10-13